Back

Antithrombotic strategies in patients with aortic bio prostheses, what is the optimal treatment

28 August 2017 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Completing the valvular heart disease puzzle Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Christina Christersson

Uppsala University, Uppsala (Sweden)

6 More presentations in this session

Presentation thumbnail
Risk factors for aortic stenosis and aortic valve replacement in 1.2 million UK women
Doctor B. Cairns (Oxford, GB)
Abstract Slides
Presentation thumbnail
Prophylactic antiplatelet therapy is superior to anticoagulation after surgical bioprosthetic aortic valve replacement: a meta-analysis and meta-regression
Doctor M. Makkiya (The Bronx, US)
Abstract Slides
Presentation thumbnail
Coronary evaluation before valvular heart surgery - prospective validation of the CT-Valve score
Mr R. Hasselbalch (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Predictors of immediate results and very long-term follow-up after percutaneous mitral balloon valvuloplasty in rheumatic mitral stenosis
Doctor R. Meneguz Moreno (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Six-month results of transcatheter edge-to-edge repair of severe tricuspid regurgitation
Professor J. Hausleiter (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
Completing the valvular heart disease puzzle

The Event

Event poster

ESC Congress 2017

28 August 2017 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources